首页> 外文期刊>Innovation in aging. >Partnering With Hospices to Develop, Test, and Implement Aliviado Dementia Care in a 25-Site Pragmatic Trial
【24h】

Partnering With Hospices to Develop, Test, and Implement Aliviado Dementia Care in a 25-Site Pragmatic Trial

机译:在25个网站务实的审判中与宾馆合作开发,测试和实施AliviaDo Dementia护理

获取原文
           

摘要

Abstract Almost half of hospice patients currently have a diagnosis of dementia. However, few pragmatic, evidence-based, programs have been developed and tested in this setting overall, and targeting persons living with dementia and their caregivers specifically. Furthermore, limited academic-hospice research partnership exist. We thus undertook efforts to develop and test Aliviado Dementia Care-Hospice Edition, a complex multi-modal quality improvement intervention, as part of the HAS-QOL Trial, a 2-phase, 25 site embedded pragmatic clinical trial, through partnership and engagement with hospice and caregiver stakeholders. We discuss methods for engagement and barriers to implementation. Stakeholders assisted with alignment of the intervention to their needs and how to flexibly implement, substantially strengthening the intervention. They also provided important input regarding how to sustain the intervention through technological, mentorship and communication support mechanisms. Barriers found include the nature of implementing in limited resource settings with multiple competing priorities and little research infrastructure.
机译:摘要近一半的临终关乳患者目前诊断痴呆症。然而,很少有务实,证据,方案已经在整个环境中开发和测试,并针对痴呆症和他们的护理人员的目标。此外,存在有限的学术临终关怀研究伙伴关系。因此,我们开发和测试AliviaDo Dementia Care-Hospice版,复杂的多模态质量改善干预措施,作为Has-QOL试验的一部分,通过伙伴关系和参与其中2阶段,25个网站嵌入式临床试验临终关怀和照顾者利益相关者。我们讨论实现的参与和障碍的方法。利益攸关方协助干预对其需求以及如何灵活地实施,大大加强干预。他们还提供了关于如何通过技术,指导和沟通支持机制维持干预的重要意义。发现的障碍包括在有限的资源环境中实施具有多种竞争优先级和小型研究基础设施的性质。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号